Option Care Health (NASDAQ:OPCH) Raised to Buy at Wall Street Zen

Option Care Health (NASDAQ:OPCH) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other analysts have also weighed in on OPCH. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $24.00 target price (down from $26.00) on shares of Option Care Health in a report on Thursday. Stephens reiterated an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Barrington Research lowered their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. TD Cowen dropped their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 target price on the stock. in a research report on Friday, May 1st. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $29.92.

Option Care Health Stock Performance

Option Care Health stock opened at $23.03 on Friday. Option Care Health has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The stock has a market cap of $3.45 billion, a P/E ratio of 17.32, a price-to-earnings-growth ratio of 1.38 and a beta of 0.65. The firm’s fifty day moving average price is $21.49 and its 200-day moving average price is $26.76.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company’s revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, equities research analysts expect that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In related news, Director Timothy P. Sullivan acquired 24,154 shares of Option Care Health stock in a transaction that occurred on Thursday, May 7th. The stock was bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the transaction, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. This represents a 49.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds have recently added to or reduced their stakes in the stock. Norges Bank bought a new position in Option Care Health in the 4th quarter worth about $61,787,000. Gamco Investors INC. ET AL increased its stake in Option Care Health by 36.8% during the 4th quarter. Gamco Investors INC. ET AL now owns 369,002 shares of the company’s stock valued at $11,756,000 after purchasing an additional 99,244 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. purchased a new position in Option Care Health in the first quarter worth about $70,287,000. Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in Option Care Health in the first quarter worth about $5,193,000. Finally, Nippon Life Global Investors Americas Inc. purchased a new position in Option Care Health in the fourth quarter worth about $3,597,000. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.